{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-028031","form_type":"8-K","ticker":"NVAX","cik":"0001000694","company_name":"NOVAVAX INC","filed_at":"2023-03-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.388174+00:00","generated_at":"2026-06-18T14:00:14.982340+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Novavax President of R&D Dr. Gregory Glenn to retire effective March 31, 2023","bullets":["Dr. Gregory M. Glenn notified Novavax of his retirement as President, Research and Development.","Retirement effective March 31, 2023; he will become Strategic Research & Development Advisor.","No successor named in the filing; consulting services to follow retirement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-028031","json":"https://secwatch.observer/filing/0001104659-23-028031.json","markdown":"https://secwatch.observer/filing/0001104659-23-028031.md","text":"https://secwatch.observer/filing/0001104659-23-028031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1000694/000110465923028031/0001104659-23-028031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1000694/000110465923028031/tm238420d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T14:00:14.982340+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8398a710f5","claim":"Dr. Gregory M. Glenn retired as President, Research and Development at NOVAVAX INC.","evidence_excerpt":"On February 28, 2023, Dr. Gregory M. Glenn, M.D. notified Novavax Inc. (the “Company”) of his decision to retire as President, Research and Development, effective as of March 31, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465923028031/0001104659-23-028031-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"President, Research and Development"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}